(Shutterstock) (Shutterstock)
blocked arteries Israel
good_news_from_israel_890x1002

Israel’s Eximo has successfully completed a multicenter clinical trial of its laser system and unique catheters for treating peripheral artery disease, and after 100% successful Mexican and European trials it has now been approved by Israel’s Ministry of Health and administered to a patient at Beilinson Hospital.

By: Michael Ordman

 

ISRAEL’S MEDICAL ACHIEVEMENTS

Successful trial of blocked artery treatment

Israel’s Eximo has successfully completed a multicenter clinical trial of its laser system and unique catheters for treating peripheral artery disease (PAD). Doctors cured 20 patients, some of whom otherwise required bypass surgery or leg amputation.
http://www.globes.co.il/en/article-eximo-succeeds-in-trial-of-blocked-artery-treatment-1001115579

Prostate cancer treatment goes live

After 100% successful Mexican and European trials it has now been approved by Israel’s Ministry of Health and administered to a patient at Beilinson Hospital.
http://www.ynetnews.com/articles/0,7340,L-4787207,00.html

Nanotech antioxidant protection

Researchers at the Hebrew University of Jerusalem and Israel’s Technion have activated the body’s natural defense against free radical damage. Enhanced micro-emulsion liquids produce a powerful antioxidant protein called Nrf2 and nanotechnology delivers it to the skin and organs.
http://www.israel21c.org/nanotech-formula-could-be-skins-fount-of-youth/
http://www.mdpi.com/2079-9284/3/1/1/htm

Detecting diseases at cell level

Researchers at the Hebrew University of Jerusalem have developed a disease diagnostic method called methylation which identifies the source of fragmented DNA caused by cell death. In tests on 320 patients it has identified pancreatic cancer, pancreatitis, diabetes, traumatic brain injury and MS.
http://www.israelnationalnews.com/News/News.aspx/209423#.VwO5Fkfn95R
http://www.pnas.org/content/113/13/E1826.abstract

http://new.huji.ac.il/en/article/29796

Bionic heart patch unveiled

Tel Aviv Professor Tal Dvir has unveiled his remote-controlled, bionic heart patch, which researchers say could become a revolutionary alternative to heart transplants for patients whose hearts have been damaged by heart attacks or cardiac disease.
http://www.timesofisrael.com/tel-aviv-u-unveils-revolutionary-cyborg-heart-patch/
http://www.nature.com/nmat/journal/vaop/ncurrent/full/nmat4590.html

Sleep apnea solution goes global

At the 13th International Dead Sea Symposium on Innovations in Technology, Treatment & Prevention of Cardiac Arrhythmias, Israel’s Itamar Medical announced that 60 international hospitals have now adopted Itamar’s Total Sleep Solution.
http://www.timesofisrael.com/how-sleep-apnea-causes-heart-attacks-and-how-israeli-tech-helps/

An implant to treat spinal degenerative disc disease

Israel’s Rainbow Medical is working with with Medos International Sarl (part of Johnson & Johnson) to develop a minimally invasive implant to treat spinal degenerative disc disease – which has no current cure and leads to acute chronic back pain.
http://www.orthospinenews.com/rainbow-medical-to-collaborate-with-johnson-johnson-innovation/

The lengths Israel goes to save Syrian girl

Doctors at Haifa’s Rambam Medical Center healed a 5-year-old Syrian girl from her civil war wounds but then discovered she had cancer. Israeli security services mounted a secret operation to smuggle a relative with matching bone marrow from “an enemy state” into Israel.
http://www.timesofisrael.com/israeli-doctors-spies-rally-to-save-5-year-old-syrian-girl/

Fighting the Zika virus

One of the Grand Challenge Israel winners is Israeli startup BioFeed. It will use the 500,000-shekel prize money to advance its solution in the fight against the Aedes aegypti mosquito, carrier of the Zika virus. Biofeed uses odor to attract insects to poison that eliminates the pest without spraying crops.
http://www.timesofisrael.com/israeli-start-up-takes-on-grand-challenge-of-beating-zika/

 

Click here for all of this week’s Good News from Israel.